Naked Brand (NAKD) 10-Q 11 Dec 15 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Oct. 31, 2015	Dec. 09, 2015
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Oct. 31, 2015
Trading Symbol	nakd
Entity Registrant Name	NAKED BRAND GROUP INC.
Entity Central Index Key	1,383,097
Current Fiscal Year End Date	--07-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		1,755,005
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q3

Interim Condensed Consolidated

Interim Condensed Consolidated Balance Sheets - USD ($)	Oct. 31, 2015	Jan. 31, 2015
Current assets
Cash	$ 318,237	$ 1,943,235
Accounts receivable, net	165,046	99,145
Inventory, net	1,341,387	183,226
Deferred costs	50,000	0
Prepaid expenses and deposits	30,948	383,651
Total current assets	1,905,618	2,609,257
Equipment, net	16,429	21,141
Intangible assets, net	71,935	44,156
Deferred costs	22,066	43,422
TOTAL ASSETS	2,016,048	2,717,976
Current liabilities
Accounts payable and accrued liabilities	845,006	299,887
Interest payable	176,194	62,650
Factored line of credit	580,407	0
Promissory notes payable	3,450	3,450
Total current liabilities	1,605,057	365,987
Deferred compensation	203,702	170,369
Convertible promissory notes	651,363	605,850
Derivative financial instruments	0	3,799,950
TOTAL LIABILITIES	2,460,122	4,942,156
STOCKHOLDERS' EQUITY (CAPITAL DEFICIT)
Common stock Authorized 11,250,000 common shares, par value $0.001 per share Issued and outstanding 1,755,005 common shares (January 31, 2015: 1,010,391)	1,755	1,011
Common stock to be issued	15,000	15,000
Accumulated paid-in capital	35,346,186	25,083,735
Accumulated deficit	(35,800,770)	(27,317,681)
Accumulated other comprehensive income (loss)	(6,245)	(6,245)
Total stockholders' equity (capital deficit)	(444,074)	(2,224,180)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (CAPITAL DEFICIT)	$ 2,016,048	$ 2,717,976

Interim Condensed Consolidated3

Interim Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Oct. 31, 2015	Jan. 31, 2015
Common Stock, Shares Authorized	11,250,000	11,250,000
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares, Issued	1,755,005	1,010,391
Common Stock, Shares, Outstanding	1,755,005	1,010,391

Interim Condensed Consolidated4

Interim Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2015	Oct. 31, 2014	Oct. 31, 2015	Oct. 31, 2014
Net sales	$ 317,748	$ 145,790	$ 938,157	$ 430,590
Cost of sales	249,274	132,447	664,081	668,253
Gross profit (loss)	68,474	13,343	274,076	(237,663)
Operating Expenses
General and administrative expenses	3,371,705	2,928,788	8,670,296	4,379,802
Foreign exchange	1,778	6,790	729	18,764
Total operating expenses	3,373,483	2,935,578	8,671,025	4,398,566
Operating loss	(3,305,009)	(2,922,235)	(8,396,949)	(4,636,229)
Other income (expense)
Interest expense	(133,432)	(116,760)	(494,788)	(218,118)
Accretion of debt discounts and finance charges	(94,980)	19,863	(300,252)	(2,263,122)
Derivative expense	0	0	0	(12,028,383)
Gain (loss) on extinguishment of debt	0	15,555	0	(810,765)
Debt conversion expense	0	0	0	(309,011)
Fair value mark-to-market adjustments	0	10,231,200	708,900	(2,773,982)
Total other income (expense)	(228,412)	10,149,858	(86,140)	(18,403,381)
Net income (loss) for the period	$ (3,533,421)	$ 7,227,623	$ (8,483,089)	$ (23,039,610)
Net income (loss) per share
Basic	$ (2.08)	$ 7.94	$ (6.51)	$ (25.94)
Diluted	$ (2.08)	$ (0.59)	$ (6.51)	$ (25.94)
Weighted average shares outstanding
Basic	1,695,437	910,089	1,302,714	888,265
Diluted	1,695,437	4,901,600	1,302,714	888,265

Interim Condensed Consolidated5

Interim Condensed Consolidated Statement of Changes in Stockholders Equity - 9 months ended Oct. 31, 2015 - USD ($)	Common Stock [Member]	Accumulated Paid-In Capital [Member]	Common stock to be issued [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Beginning Balance at Jan. 31, 2015	$ 1,011	$ 25,083,735	$ 15,000	$ (27,317,681)	$ (6,245)	$ (2,224,180)
Beginning Balance (Shares) at Jan. 31, 2015	1,010,391
Shares issued pursuant the conversion of debt	$ 79	236,985				237,064
Shares issued pursuant the conversion of debt (Shares)	79,025
Shares issued in settlement of debt	$ 2	11,998				12,000
Shares issued in settlement of debt (Shares)	2,500
Shares issued as payment in kind for interest owing under convertible debt arrangements	$ 55	280,176				280,231
Shares issued as payment in kind for interest owing under convertible debt arrangements (Shares)	55,377
Shares issued pursuant to the exercise of amended warrants	$ 586	2,342,410				2,342,996
Shares issued pursuant to the exercise of amended warrants (Shares)	585,705
Less: commissions paid		(91,422)				(91,422)
Rounding shares issued in connection with reverse stock split	$ 22	(22)
Rounding shares issued in connection with reverse stock split (shares)	22,007
Derivative liability reclassifications		3,091,050				3,091,050
Stock based compensation		4,391,276				4,391,276
Net loss for the period				(8,483,089)		(8,483,089)
Ending Balance at Oct. 31, 2015	$ 1,755	$ 35,346,186	$ 15,000	$ (35,800,770)	$ (6,245)	$ (444,074)
Ending Balance (Shares) at Oct. 31, 2015	1,755,005

Interim Condensed Consolidated6

Interim Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Oct. 31, 2015	Oct. 31, 2014
Cash flows from operating activities
Net loss for the period	$ (8,483,089)	$ (23,039,610)
Adjustments to reconcile net loss to net cash used in operating activities:
Provision for (recovery of) doubtful accounts	20,226	(3,612)
Provision for obsolete inventory	0	290,000
Depreciation and amortization	13,526	19,181
Other non cash items (Schedule 1)	3,982,628	19,854,719
Unrealized foreign exchange	0	2,760
Finance fees paid in connection with debt extinguishment	0	(38,008)
Finance fees paid in connection with long term debt offering	0	525,113
Changes in operating assets and liabilities:
Accounts receivable	(86,127)	(43,121)
Prepaid expenses and deposits	352,703	(9,325)
Inventory	(1,158,161)	53,065
Deferred costs	(50,000)	50,000
Accounts payable	556,874	(256,854)
Interest payable	397,702	172,438
Deferred compensation	33,333	103,703
Net cash used in operating activities	(4,420,385)	(2,319,551)
Cash flows from investing activities
Acquisition of intangible assets	(32,155)	(22,535)
Purchase of equipment	(4,439)	(19,888)
Net cash used in investing activities	(36,594)	(42,423)
Cash flows from financing activities
Proceeds from share issuances	2,342,996	0
Share issuance offering costs	(91,422)	0
Proceeds from share subscriptions received	0	0
Proceeds from the issuance of promissory notes	0	927,168
Repayments of promissory notes	0	(413,385)
Proceeds from convertible promissory notes	0	6,094,100
Repayments of convertible promissory notes	0	(364,640)
Debt offering costs	0	(616,237)
Repayments on factoring arrangements	(429,593)	0
Advances under factoring arrangements	1,010,000	0
Net cash provided by financing activities	2,831,981	5,627,006
Net increase (decrease) in cash	(1,624,998)	3,265,032
Cash at beginning of the period	1,943,235	67,478
Cash at end of the period	318,237	3,332,510
Cash paid during the period for:
Interest	70,923	30,127
Taxes	0	0
Non-cash financing activities:
Extinguishment of accounts payable with equity	12,000	11,158
Repayment of promissory note through the issuance of new promissory note	0	205,083
Settlement of notes through the issuance of shares	0	299,444
Reclassification of derivative liability to additional paid in capital	3,091,050	0
Conversion of convertible debt to shares	233,382	0
Interest paid in shares	283,913	0
Profit and loss items not involving cash consists of:
Shares to be issued in exchange for services	0	39,900
Loss on extinguishment of debt	0	810,765
Stock based compensation	4,391,276	2,094,586
Derivative expense	0	12,028,383
Change in fair value of derivative financial instruments	(708,900)	2,773,982
Debt issuance costs paid in warrants	0	1,552,700
Debt conversion expense	0	309,011
Amortization of deferred financing fees	21,356	142,043
Interest capitalized to convertible debt	0	10,372
Shares issued as penalty under debt agreements	0	1,250
Accretion of debt discount	278,896	91,727
Total Other items not involving cash	$ 3,982,628	$ 19,854,719

Nature of Business

Nature of Business	9 Months Ended
	Oct. 31, 2015
Nature of Business [Text Block]	1. Nature of Business Naked Brand Group Inc. (the “Company”) is a manufacturer and seller of direct and wholesale men’s and women’s undergarments and intimate apparels in the United States and Canada to consumers and retailers through its wholly owned subsidiary, Naked Inc. (“Naked”). In the future, the Company plans to expand into other apparel and product categories. The Company currently operates out of New York, United States of America. Effective August 10, 2015, the Company effected a reverse stock split of the basis of 1:40. As such, the Company’s authorized capital was decreased from 450,000,000 shares of common stock to 11,250,000 shares of common stock and an aggregate of 53,278,818 shares of common stock issued and outstanding were decreased to 1,331,977 shares of common stock. These financial statements give retroactive effect to such reverse split and all share and per share amounts have been adjusted accordingly.

Ability to Continue as a Going

Ability to Continue as a Going Concern	9 Months Ended
	Oct. 31, 2015
Ability to Continue as a Going Concern [Text Block]	2. Ability to Continue as a Going Concern These unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) on a going concern basis, which assumes that the Company will continue to realize its assets and discharge its obligations and commitments in the normal course of operations. Realization values may be substantially different from carrying values as shown and these consolidated financial statements do not give effect to adjustments that would be necessary to the carrying values and classification of assets and liabilities should the Company be unable to continue as a going concern. As of October 31, 2015, the Company had not yet achieved profitable operations and expects to incur significant further losses in the development of its business, which casts substantial doubt about the Company’s ability to continue as a going concern. To remain a going concern, the Company will be required to obtain the necessary financing to pursue its plan of operation. Management plans to obtain the necessary financing through the issuance of equity and/or debt. Should the Company not be able to obtain this financing, it may need to substantially scale back operations or cease business. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis of Presentation

Basis of Presentation	9 Months Ended
	Oct. 31, 2015
Basis of Presentation [Text Block]	3. Basis of Presentation Interim Financial Statements The accompanying unaudited condensed consolidated interim financial statements have been prepared by management, without audit, in accordance with the rules and regulations of the Securities and Exchange Commission. Accordingly, certain information and footnote disclosures normally included in the annual consolidated financial statements in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In the opinion of management, the disclosures are adequate to make the information presented not misleading and the accompanying financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for fair presentation of statement of financial position, results of operations and cash flows for the interim periods presented. Operating results for the nine months ended October 31, 2015 are not necessarily indicative of the results that may be expected for the year ending January 31, 2016. The consolidated balance sheet at January 31, 2015 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by United States generally accepted accounting principles for annual financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the most recent audited financial statements of the Company included in its annual report on Form 10-K for the year ended January 31, 2015. Fair Value of Financial Instruments The Company accounts for its financial assets and liabilities in accordance with ASC Topic 820, Fair Value Measurements and Disclosures Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals; Level 3 inputs are unobservable inputs for the asset or liability which are typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. The Company’s financial instruments consist of cash, accounts receivable, accounts payable, interest payable, notes payable, factored line of credit and convertible promissory notes. Other than convertible promissory notes, the fair values of these financial instruments approximate their respective carrying values because of the short maturity of these instruments. The Company determined that the aggregate fair value of promissory notes payable outstanding at October 31, 2015 and January 31, 2015, based on Level 2 inputs in the fair value hierarchy, was equal to their aggregate book value based on the short maturities and current borrowing rates available to the Company. The fair value of the Company’s convertible promissory notes is based on Level 3 inputs in the fair value hierarchy. The Company calculated the fair value of these notes by discounting future cash flows using rates representative of current borrowing rates for debt instruments without a conversion feature and by using the Black Scholes option pricing model to determine the fair value of the conversion feature using the following assumptions: October 31, 2015 January 31 2015 Risk-free interest rate 0.66% 0.61% Expected life (years) 1.59 2.34 Expected volatility (1) 133.05% 147.42% Stock price $ 3.18 $ 4.80 Dividend yields 0.00% 0.00% (1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities. The Company determined that the fair value of the convertible promissory notes at October 31, 2015 was $14,110,100 (January 31, 2015: $15,476,300) based on a market interest rate of 18%. Segment Reporting The Company used several factors in identifying and analyzing reportable segments, including the basis of organization, such as differences in products and services, and geographical areas. The Company’s chief operating decision makers review financial information presented on a consolidated basis for the purposes of making operating decisions and assessing financing performance. Accordingly, the Company has determined that as of October 31, 2015 and January 31, 2015, there is only a single reportable operating segment. The Company operates in one industry, the manufacture and sale of direct and wholesale undergarments. Revenues from external customers are all derived from customers located within North America as follows: Three months ended Nine months ended October 31, October 31, 2015 2014 2015 2014 United States $ 267,448 $ 78,840 722,039 $ 270,003 Canada 50,300 66,950 216,118 160,587 $ 317,748 $ 145,790 938,157 $ 430,590 At October 31, 2015 and January 31, 2015, the net book value of long-lived assets all located within North America were as follows: October 31, 2015 January 31, 2015 Equipment Intangible assets Equipment Intangible assets United States $ 9,793 $ 41,990 $ 12,688 $ 14,211 Canada 6,636 29,945 8,453 29,945 $ 16,429 $ 71,935 $ 21,141 $ 44,156 Loss per share Net loss per share was determined as follows: Three months ended October 31, Nine months ended October 31, 2015 2014 2015 2014 Numerator Net income (loss) $ (3,533,421 ) 7,227,623 $ (8,483,089 ) $ (23,039,610 ) Less: Adjustment to income - (10,103,774 ) - - $ (3,533,421 ) $ (2,876,151 ) $ (8,483,089 ) $ (23,039,610 ) Denominator Weighted average common shares outstanding 1,695,437 910,089 1,302,714 888,265 Effect of dilutive securities Warrants - 1,494,900 - - Convertible debt - 2,496,611 - - Diluted weighted average common shares outstanding 1,695,437 4,901,600 1,302,714 888,265 Basic net income (loss) per share $ (2.08 ) $ 7.94 $ (6.51 ) $ (25.94 ) Diluted net income (loss) per share $ (2.08 ) $ (0.59 ) $ (6.51 ) $ (25.94 ) Anti-dilutive securities not included in diluted loss per share relating to: Warrants and options outstanding 3,712,167 1,951,874 3,712,167 3,446,774 Convertible debt 2,372,150 - 2,372,150 2,496,611 6,084,317 1,951,874 6,084,317 5,943,385 New Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (the “FASB”), which are adopted by the Company as of the specified date. Unless otherwise discussed, management believes the impact of recently issued standards, which are not yet effective, will not have a material impact on our consolidated financial statements upon adoption. On May 28, 2014, the FASB and the International Accounting Standards Board (IASB) issued a converged standard on revenue recognition from contracts with customers, ASU 2014-09 (Topic 606 and IFRS 15). This standard will supersede nearly all existing revenue recognition guidance. ASU 2014-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company is currently evaluating the impact this guidance will have on its financial condition, results of operations and cash flows. In June 2014, the FASB issued ASU No. 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (“ASU 2014-12”). ASU 2014-12 requires that a performance target that affects vesting, and that could be achieved after the requisite service period, be treated as a performance condition. As such, the performance target should not be reflected in estimating the grant date fair value of the award. This update further clarifies that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. The amendments in this ASU are effective for annual periods and interim periods within those annual periods beginning after December 15, 2015. The Company is currently evaluating the impact this guidance will have on its financial condition, results of operations and cash flows. In August 2014, the FASB issued ASU No. 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern (“ASU 2014-15”). ASU 2014-15 will explicitly require management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. The Company is currently evaluating the impact this guidance will have on its financial condition, results of operations and cash flows. In April 2015, the Financial Accounting Standards Board (FASB), issued the Accounting Standards Update 2015-03, Interest - Imputation of Interest (Subtopic 835-30) - Simplifying the Presentation of Debt Issuance Costs, that requires debt issuance costs related to a recognized debt liability to be presented in the balance sheet as a direct deduction from the debt liability rather than as an asset. For public business entities, the final guidance will be effective for fiscal years beginning after December 15, 2015, however, early adoption (including in interim periods) is permitted. Upon adoption, an entity must apply the new guidance retrospectively to all prior periods presented in the financial statements. An entity is also required in the year of adoption to provide certain disclosures about the change in accounting principle, including the nature of and reason for the change, the transition method, a description of the prior-period information that has been retrospectively adjusted and the effect of the change on the financial statement line items (that is, debt issuance cost asset and the debt liability). The Company plans to adopt this standard beginning February 1, 2016. The Company is currently evaluating the impact this guidance will have on its financial condition, results of operations and cash flows.

Inventory

Inventory	9 Months Ended
	Oct. 31, 2015
Inventory [Text Block]	4. Inventory Inventory of the Company consisted of the following: October 31, January 31, 2015 2015 Finished goods $ 1,423,185 $ 362,226 Raw materials 9,202 - 1,432,387 362,226 Less: allowance for obsolete inventory (91,000 ) (179,000 ) Total inventory $ 1,341,387 $ 183,226 Balances at October 31, 2015 and January 31, 2015 are recorded at historical cost, less amounts for potential declines in value. At October 31, 2015, management has recorded an allowance for obsolescence of $91,000 (2015: $179,000) to reduce inventory to its estimated net realizable value.

Equipment

Equipment	9 Months Ended
	Oct. 31, 2015
Equipment [Text Block]	5. Equipment Equipment of the Company consisted of the following at October 31, 2015 and January 31, 2015: October 31, January 31, 2015 2015 Furniture & equipment $ 10,250 $ 11,630 Computer equipment 25,400 20,963 35,650 32,593 Less: Accumulated depreciation (19,221 ) (11,452 ) $ 16,429 $ 21,141 Depreciation expense for the three and nine month periods ended October 31, 2015 was $2,943 and $9,151, respectively (2014: $2,155 and $4,179, respectively).

Intangible Assets

Intangible Assets	9 Months Ended
	Oct. 31, 2015
Intangible Assets [Text Block]	6. Intangible Assets Intangible assets of the Company consisted of the following at October 31, 2015 and January 31, 2015: October 31, January 31, Useful life 2015 2015 (Years) Trade Names/Trademarks $ 71,935 $ 39,781 Indefinite Website 49,512 49,512 2 121,447 89,293 Less: accumulated amortization (49,512 ) (45,137 ) $ 71,935 $ 44,156 Amortization expense for the three and nine month periods ended October 31, 2015 was $Nil and $4,375, respectively (2014: $3,874 and $15,002, respectively).

Related Party Transactions and

Related Party Transactions and Balances	9 Months Ended
	Oct. 31, 2015
Related Party Transactions and Balances [Text Block]	7. Related Party Transactions and Balances Related Party Balances At October 31, 2015, included in accounts payable and accrued liabilities is $24,186 (January 31, 2015: $17,060) owing to a director and officer of the Company for reimbursable expenses, an officer of the Company for an accrued management bonus and a former director and officer of the Company for an accrued management bonus. These amounts are unsecured, non-interest bearing with no specific terms of repayment. At October 31, 2015, an amount of $953,779 (January 31, 2015: $978,779) in principal amounts of convertible notes payable and $22,420 in accrued interest payable (January 31, 2015: $8,247), was owing to directors and officers of the Company. Included in convertible notes payable at October 31, 2015 is an amount of $7,063 (January 31, 2015: $791) in respect of these amounts owing, after applicable unamortized debt discounts. Related party transactions During the three and nine months ended October 31, 2015, included in general and administrative expenses is $1,612,952 and $4,017,737, respectively (2014: $1,872,467 and $1,975,515, respectively) in respect of share based compensation expense for the vesting of stock options granted to directors and officers of the Company, and $71,646 and $230,728, respectively (2014: $43,500 and $89,000, respectively) in respect of marketing fees paid to a firm of which a direct family member of a director and officer of the Company is a principal. Pursuant to a board agreement dated September 24, 2013, the Company agreed to issue 1,875 shares of common stock every three months over the term of the one year contract in connection with the appointment of a director of the Company, for an aggregate of 7,500 common shares over the term. During the three and nine months ended October 31, 2015, the Company recorded directors fees of $Nil (2014: $43,500 and $157,300, respectively) in respect of common shares earned under this agreement. The fair values per share were determined with reference to the quoted market price of the Company’s shares on the date these shares were committed to be issued. Effective June 10, 2014, the Company entered into an employment agreement with the Chief Executive Officer and Director (the “CEO”) of the Company for a term of three years whereby (a) the CEO shall be entitled to a base salary of $400,000 per year, provided the CEO will forgo the first twelve months of the base salary and only receive minimum wage during that period; (b) the CEO received a sign-on stock option grant to purchase 1,428,750 shares of common stock of the Company, equal to 20% of the issued and outstanding shares of common stock of the Company on a fully-diluted basis, (the “CEO Options”), with each option exercisable at $5.12 per share and vesting in equal monthly instalments over a period of three years from the date of grant; and (c) the CEO will be eligible to receive an annual cash bonus for each whole or partial year during the employment term payable based on the achievement of one or more performance goals established annually by the Company’s board of directors. In connection with this employment agreement, the Company issued 2,500 common shares to a consultant of the Company. The fair value of $4.80 per share was determined with reference to the quoted market price of the Company’s shares on the date these shares were committed to be issued. At October 31, 2015, an amount of $203,702 (January 31, 2015: $170,369) is included in deferred compensation, relating to the amortization of total base salary compensation due under this employment agreement, which is being amortized on a straight line basis over the term of the employment agreement. On June 10, 2015, the CEO became eligible to receive her full base salary pursuant to the terms of her employment agreement, however, such base salary has not yet been paid as of October 31, 2015. The Company accrued base salary compensation payable of $166,665 during the nine months ended October 31, 2015, and the CEO has agreed to allow the Company to defer payment of such amounts until such time as the Company closes a currently contemplated underwritten public offering of its common stock. Such deferred and unpaid base salary will accrue interest at a rate of 3% per annum. Upon closing of the currently contemplated underwritten public offering, the Company has agreed to issue the CEO shares of its common stock with a fair market value equal to, and in lieu of, the cash amount owing for all deferred and unpaid base salary, plus interest up to the date of settlement. Following the date of settlement, the CEO will receive her base salary compensation in cash pursuant to the original terms of her employment agreement. Effective June 9, 2014, the Company entered into an employment agreement with the Chief Financial Officer (the “CFO”) of the Company for a term of four years whereby (a) the CFO shall be entitled to a base salary of $200,000 per year; and (b) the CFO received a sign-on stock option grant to purchase 70,000 shares of common stock of the Company (the “CFO Options”), with each option exercisable at $5.12 per share and vesting annually over a period of four years from the date of grant. Effective June 23, 2014, the Company entered into an employment agreement with an officer (the “Officer”) of the Company for a term of four years whereby (a) the Officer shall be entitled to a base salary of $175,000 per year; and (b) the Officer received a sign-on stock option grant to purchase 92,500 shares of common stock of the Company (the “Officer Options”), with each option exercisable at $5.12 per share and vesting annually over a period of four years from the date of grant.

Factoring Line of Credit

Factoring Line of Credit	9 Months Ended
	Oct. 31, 2015
Factoring Line of Credit [Text Block]	8. Factoring Line of Credit On June 11, 2015, the Company entered into a factoring agreement (the “Factoring Agreement”) with Capital Business Credit LLC (the “Factor”) whereby the Company may borrow the lesser of (i) $750,000 or (ii) the sum of up to 80% of trade receivables, 60% of finished goods inventory and 100% of any accepted side collateral, under the terms and conditions as outlined in the Factoring Agreement. A director and officer of the Company has provided side collateral supporting a portion of the borrowings under the Factor Agreement. The facility is secured by a general security interest over all of the Company assets and interests. The term of the agreement is for a period of one year and will automatically renew for additional one year terms, unless terminated at any time by the Factor or by the Company prior to such renewal, with thirty days prior written notice. Under the terms of the Factoring Agreement, the Company may sell and assign eligible accounts receivable to the Factor in exchange for advances made to the Company. The Factor purchases eligible accounts receivable net of a factoring commission of 0.9% of such receivable. The Company bears the risk of credit loss on the receivable, except where the Factor has provided credit approval in writing on such receivable. These receivables are accounted for as a secured borrowing arrangement and not a sale of financial assets. Factor expenses charged to operations during the three and nine months ended October 31, 2015 were $14,147 and $24,500 respectively (2014: $Nil and $Nil, respectively). The facility bears interest on the daily net balance of any moneys owed at a rate of the greater of (i) 5.5% per annum; and (ii) 2% above the Prime Rate as quoted in the Wall Street Journal (the “Prime Rate”). At October 31, 2015, the Prime Rate was 3.25%, thus the facility was bearing interest at 5.5% . To the extent that net advances owing exceed the borrowing base described above, additional interest of 1% per annum shall be charged based upon the daily balance of any such over advance. At October 31, 2015, an amount of $580,407 (January 31, 2015: $Nil) was owing under the terms of the Factoring Agreement, for advances made to the Company, net of repayments of such advances through the collection of factored receivables.

Promissory Notes Payable

Promissory Notes Payable	9 Months Ended
	Oct. 31, 2015
Promissory Notes Payable [Text Block]	9. Promissory Notes Payable (i) On November 7, 2013, the Company issued a promissory note in the principal amount of CDN$28,750. The Company received $24,467 (CDN$25,000) in respect of this note, after an original issue discount (“OID”) of 15%, or $3,670 (CDN$3,750). The principal amount, net of the OID, matured and was repaid during the nine months ended October 31, 2014. At October 31, 2015, an amount of $3,450 (CDN$3,750) (January 31, 2015: $3,450 (CDN$3,750)) is outstanding relating to the OID, which is repayable upon the Company reporting net income from operations in any single month. (ii) On April 7, 2014, the Company entered into a Securities Purchase Agreement with certain purchasers pursuant to which the Company agreed to issue 6% Senior Secured Convertible Promissory Notes (the “SPA Notes”) in the aggregate principal amount of $1,083,797. As consideration, the Company (i) received cash proceeds equal to $878,704 (the “Cash Proceeds”); (ii) exchanged a promissory note with an outstanding amount of $76,388, being the principal and accrued interest due under a convertible promissory note dated December 24, 2013 for the issuance of a SPA Note in the same amount; and (iii) exchanged a promissory note with an outstanding amount of $128,705, being the remaining principal amount due under a convertible promissory note dated October 2, 2013 for the issuance of a SPA Note in the same amount. Repayment of the SPA Notes was collateralized against all the tangible and intangible assets of the Company. The principal amount of $1,083,797 were to mature on April 7, 2015 (the “Maturity Date”) and was bearing interest at the rate of 6% per annum, payable on the Maturity Date. On June 10, 2014, these notes, along with accrued interest of $10,362 were exchanged for securities in a subsequent offering (Note 10(i)), at an exchange rate equal to 90% of the price paid by investors in that offering. During the nine months ended October 31, 2014, the Company recorded debt conversion expense of $121,573, related to this purchase price discount upon these Notes being converted for units in the subsequent offering. The Company incurred $89,849 in issuance costs in respect of the SPA Notes. During the three and nine months ended October 31, 2015, the Company recorded $Nil and $Nil, respectively (2014: $Nil and $10,372, respectively) in respect of interest on this note and $Nil and $Nil, respectively (2014: $Nil and $89,849, respectively) in respect of the accretion of deferred financing fees. (iii) During the year ended January 31, 2014, the Company received $75,000 in respect of a promissory note in the principal amount of $75,000. The promissory note matured on February 1, 2014 and was bearing interest at a rate of 10% per annum payable at maturity. During the nine months ended October 31, 2014, the Company issued 19,922 common shares of the Company in full and final settlement of this note, along with accrued interest of $4,685. This resulted in a loss on extinguishment of debt of $119,528 being recorded on the consolidated statement of operations during the nine months ended October 31, 2014. The fair value of $10 per share was determined with reference to the quoted market price of the Company’s stock on the date of issuance. (iv) On February 12, 2014, the Company issued a promissory note in the principal amount of CDN$61,295. The Company received $48,464 (CDN$53,300) in respect of this note, after an original issue discount (“OID”) of 15%, or $7,270 (CDN$7,995). The note matured and was repaid during the nine months ended October 31, 2014. (v) On January 13, 2014, the Company issued a promissory note in the principal amount of $309,062, which was comprised of: (i) $250,000 consideration received; (ii) a one-time interest charge of $37,500, being 15% of the proceeds received (the “OID”); and (iii) an amount of $21,562, being the remaining principal balance due under a separate note agreement with the same lender. The promissory note was repayable in five monthly instalments of $41,667 over the term of the note plus one final balloon payment of $63,229 at its maturity on July 13, 2014. The Company repaid this promissory note during the nine months ended October 31, 2014.

Convertible Promissory Notes Pa

Convertible Promissory Notes Payable	9 Months Ended
	Oct. 31, 2015
Convertible Promissory Notes Payable [Text Block]	10. Convertible Promissory Notes Payable October 31, 2015 January 31, 2015 Senior Secured Convertible Debentures, bearing interest at 6% per annum, collateralized by a priority general security agreement over all of the present and future assets of the company ranked pari passu to First and Second Kalamalka Amendment Agreement, due June 10, 2017 (i). $ 6,936,450 $ 7,169,832 First and Second Kalamalka Amendment Agreement, bearing interest at 6% per annum, collateralized by a priority general security agreement over all of the present and future assets of the company ranked pari passu to Senior Secured Convertible Debentures due June 10, 2017 (ii) 600,000 600,000 Less: debt discounts (6,885,087 ) (7,163,982 ) $ 651,363 $ 605,850 (i) Senior Secured Convertible Debentures On June 10, 2014 and July 8, 2014, the Company entered into Subscription Agreements (collectively, the “Subscription Agreements”) with several investors (collectively, the “Purchasers”) in connection with a private placement offering (the “Offering”) for aggregate gross proceeds of $7,309,832 through the sale of 292 units (the “Units”) at a price of $25,000 per Unit. Each Unit consisted of (i) a 6% convertible senior secured debenture in the principal amount of $25,000 (each, a “Debenture”) and (ii) warrants to purchase 4,167 of our common shares at an exercise price of $6.00 per share, subject to certain adjustment as set out in the warrant agreements (the “Warrants”). In connection with the close of the Offering, the Company issued Debentures in the aggregate principal amount of $7,309,832. As consideration, the Company (i) received gross cash proceeds equal to $6,094,100, before deducting agent fees and other transaction-related expenses; and (ii) exchanged 6% senior secured convertible notes in the aggregate amount of $1,094,159, being the principal and accrued interest due under such notes, for the issuance of Debentures in the aggregate principal amount of $1,215,732, at an exchange rate equal to 90% of the purchase price paid in the Offering. The aggregate principal amount matures on June 10, 2017 and bears interest at the rate of 6% per annum, payable quarterly, in cash or in shares of common stock, at the option of the Company provided certain equity conditions of the Debentures have been met, valued at the then conversion price of the Debentures. At October 31, 2015, such equity conditions had not been met and, consequently, payment of interest owing in shares of common stock is not permitted under the terms of the Debentures, unless such condition is formally waived by each holder. During the nine months ended October 31, 2015 and in connection with the second interest payment dates, the Company received waivers from holders of $5,537,577 in outstanding principal amounts of the Debentures. Such holders received payment of interest in shares of common stock of the Company, resulting in the issuance of 55,377 shares of our common stock as payment for $166,127 in interest due, based on a contractual conversion price of $3 applied to the cash amount of interest owing. The fair value of the shares issued of $280,231 was determined with reference to the quoted market price of the shares on the date they were issued. The difference between the fair value of the shares issued and the cash amount of interest payable was recorded as interest expense on the consolidated statement of operations for the three and nine months ended October 31, 2015. The Debentures, along with any accrued and unpaid interest thereon, may be converted at any time, at the option of the holder, into common shares of the Company at a conversion price of $3.00 per share, subject to adjustment under the terms of the Debentures. Repayment of the Debentures are collateralized against all the assets of the Company and its subsidiary, pursuant to a security agreement between the Company and an agent for the Purchasers. The Company issued an aggregate of 1,218,308 Warrants to the Purchasers to purchase, for a period of five years from the date of issuance, up to 1,218,308 shares of common stock at an initial exercise price of $6.00 per share, subject to adjustment. The Company has the right to call the Warrants if the volume weighted average closing price of its common shares exceeds $16.00 per share for more than 20 consecutive trading days at any time after June 10, 2016. In that event, the Warrants will expire 30 days following the date the Company delivers notice in writing to the Warrant holders announcing the call of the Warrants. At the date of issuance of the Debentures and Warrants, the Company was authorized to issue 2,500,000 shares of common stock, which was insufficient to settle the conversion of the Debentures and exercise of the Warrants. Consequently, under the guidance of ASC 815, management recorded a derivative financial instrument in the Company’s consolidated financial statements (Note 11). In connection with the Subscription Agreements, the Company also entered into a Registration Rights Agreement with each Purchaser (the “Registration Rights Agreement”), pursuant to which the Company agreed to file with the Securities and Exchange Commission (the “SEC”) a registration statement to register for resale the shares that have been or may be issued to the Purchasers upon conversion of the Debentures and upon exercise of the Warrants (the “Registration Statement”). The terms of the Registration Rights Agreement also trigger the requirement to account for the related embedded conversion option and investor warrants that have not been included in an effective registration statement as derivative financial instruments pursuant to the guidance of ASC 815. The Company also agreed to grant piggyback registration rights whereby the Company is required to include the shares of common stock issuable pursuant to exercise of the Agent Warrants in the Registration Statement. The Company allocated the proceeds from the issuance of the Debentures first to the derivative financial instruments, at their fair values, with the remainder being allocated to the Debentures. The fair value of the derivative financial instruments of $19,338,215 at issuance resulted in a debt discount at issuance of $7,309,832, the entire aggregate principal balance of the Debentures. The remaining derivative financial instruments value over the proceeds of the debt at issuance of $12,028,383 was immediately expensed on the consolidated statement of operations as derivative expense, during the year ended January 31, 2015. This discount was being amortized using the effective interest method over the term of the Debentures. During the three and nine months ended October 31, 2015, the Company recorded accretion expense of $26,927 and $45,867, respectively (2014: $1,684 and $2,205, respectively) in accretion of this discount. In connection with the Offering, the Company incurred finance fees of $2,021,213 as follows: (i) The Company paid a cash commission of $468,513, or 8% of the gross proceeds raised from certain of the Purchasers; (ii) The Company issued 276,592 warrants to acquire common shares equal to 8% of the aggregate number of shares issuable upon conversion of the Debentures and exercise of the Warrants with respect to certain of the Purchasers (the “Agent Warrants”), on the same terms as the Warrants, except that the Agent Warrants are (i) exercisable at 100% of the conversion or exercise price of the Debentures and Warrants issued to the Purchasers in the Offering and (ii) contain a cashless exercise provision. The fair value of the finder’s warrants of $1,552,700 was determined using an option pricing model under the following assumptions: June 10, 2014 July 8, 2014 Risk-free interest rate 1.71% 1.70% Expected life (years) 5.00 5.00 Expected volatility (1) 147.39% 147.39% Stock price at issuance $ 6.00 $ 6.50 Dividend yields 0.00% 0.00% (1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities. The finance fees were allocated to the Debentures and related derivative financial instruments in the same proportion as the allocation of proceeds to each instrument at the issuance date and, consequently, since the derivative financial instruments were allocated 100% of the proceeds, these finance charges were allocated to the derivative financial instrument at issuance and, as a result of these instruments being carried at fair value, were recorded as an immediate finance expense on the consolidated statement of operations during the nine months ended October 31, 2014. On September 8, 2014, the Company filed an initial prospectus on Form S-1 with the Securities and Exchange Commission (SEC) to register the sale of up to 1,039,227 shares issuable upon exercise of certain of the warrants issued in connection with the Offering, including 60,000 warrants issued under the Kalamalka Notes (Note 10(ii)) which contained piggyback registration rights, and 979,227 of the Warrants. On October 8, 2014, the SEC declared the registration statement effective. During the nine months ended October 31, 2015, the Company issued an aggregate of 79,025 shares of common stock pursuant to the conversion of debt, including 77,789 shares pursuant to the conversion of $233,382 in principal and 1,236 shares as payment for $3,682 in interest amounts owing under the Debentures for principal amounts converted. During the nine months ended October 31, 2015 In connection with these conversion, the Company recorded accelerated accretion expense of $232,977 (2014: $Nil). (ii) Senior Secured Convertible Note Agreements with Kalamalka Partners On August 10, 2012, and November 14, 2013, the Company and its wholly owned subsidiary, Naked, entered into certain Agency Agreements with Kalamalka and certain lenders (the “Lenders”) as set out in the Agency Agreements whereby the Company agreed to borrow up to $800,000 from the Lenders under a revolving loan arrangement by the issuance of convertible promissory notes (the “Notes”) from time to time as such funds are required by the Company. The Notes were collateralized by a first priority general security agreement over the present and future assets of the Company and were bearing interest at 12% per annum, calculated and payable monthly. The principal amounts outstanding under any Note and all accrued and unpaid interest therein, were convertible into common shares at $30 per share at any time at the option of the Lender. These terms were later amended, as described below. On November 13, 2013, the Company entered into another Agency and Interlender Agreement with Kalamalka and certain lenders whereby the Company agreed to borrow up to an additional $300,000. On April 4, 2014, the Company entered into another Amendment Agreements with Kalamalka and certain of the Lenders (the “Amendment Agreements”). In connection with the Amendment Agreements, the Company amended several of the Notes in the aggregate principal amount of $600,000 as follows; (i) the Company extended the due date of the Notes to October 1, 2016; (ii) the Company reduced the interest rate accruing under the Notes to 6% per annum, calculated and payable quarterly; (iv) the Company removed certain borrowing margin requirements; (iii) the Company reduced the conversion price on Notes in the aggregate principal amount of $400,000 from $20 per share to $10 per share; and (v) 12,500 share purchase warrants exercisable at a strike price of $20 until August 10, 2017 held by Kalamalka and 2,500 share purchase warrants at a strike price of $20 until August 10, 2018 (the “Existing Warrants”) were exchanged for 15,000 New Warrants, as defined and described below (the “Exchanged Warrants”). As consideration for facilitating such amendments, the Company granted 45,000 share purchase warrants to the Lenders and Kalamalka (the “New Warrants”). Each New Warrant issued to Kalamalka and the Lenders is exercisable into one common share at a price of $6 per share for a period of five years. The Company has the right to call the New Warrants if the volume weighted average closing price of the Company’s shares exceeds $16 per share for more than 20 consecutive trading days at any time after June 10, 2016. In that event, the New Warrants will expire 30 days following the date the Company delivers notice in writing to the warrant holders announcing the call of the Warrants. In addition, the New Warrants contained piggyback registration rights on any subsequent registration statement filed with the SEC. The New Warrants were included in the registration statement declared effective by the SEC on October 8, 2014 (Note 10(i)). The Company assessed the guidance under ASC 470-60 Troubled Debt Restructurings Risk-free interest rate 0.66% Expected life (years) 2.50 Expected volatility (1) 141.72% Stock price $ 9.20 Dividend yields 0.00% The fair value of the New Warrants of $384,100 was determined using the Black Scholes option pricing model with the following assumptions: Risk-free interest rate 1.71% Expected life (years) 5.00 Expected volatility (1) 149.76% Stock price at date of issuance $ 9.20 Dividend yields 0.00% The fair value of the Exchanged Warrants of $23,300 was determined as the difference between the fair value of these warrants exchanged and the fair value of the New Warrants received. The fair values were determined using the Black Scholes option pricing model with the following weighted average assumptions: Existing Exchanged Warrants Warrants Risk-free interest rate 0.96% 1.71% Expected life (years) 3.52 5.00 Expected volatility (1) 146.70% 149.76% Stock price at date of issuance $ 9.20 $ 9.20 Dividend yields 0.00% 0.00% (1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities. The loss was recorded on the consolidated statement of operations during the nine months ended October 31, 2014, with a corresponding credit to additional paid in capital. In connection with the Amendment Agreements, the Company incurred $36,993 in financing fees. These cost have been recorded as a deferred financing charge and are being amortized using the effective interest method over the term of the amended Notes. During the three and nine months ended October 31, 2015, the Company recorded financing expense of $7,102 and $21,356, respectively (2014: $7,006 and $16,130, respectively) in respect of the amortization of these charges. During the nine months ended October 31, 2014, the remaining Note in the aggregate principal amount of $100,000 plus $1,868 in accrued interest therein was settled by the issuance of 25,467 common shares of the Company at a conversion price of $4 per share. During the nine months ended October 31, 2014, the Company recorded debt conversion expense of $187,438, related to the fair value of the additional units issued as a result of converting at the lower conversion price than the contractual conversion rate. The fair value of the shares issued was determined with reference to their quoted market price on the date of issuance. (iii) On June 5, 2014, the Company entered into a Note Termination Agreement pursuant to which the Company agreed to settle the full amount outstanding under a convertible promissory note in the principal amount of $124,444 in exchange for (i) a one-time cash payment of $175,000 and (ii) 8,250 common shares of the Company. The promissory note had been convertible, at any time by the lender, into shares of common stock of the Company at a price which is the lesser of $0.265 or 60% of the lowest trade price in the 25 trading days prior to the conversion (the “Conversion Price”). This resulted in a loss on extinguishment of debt of $38,405, being the fair value of aggregate consideration given of $217,240 less the book value of this Note of $3,735 (after a debt discount of $120,709) and a related embedded conversion feature being accounted for as a derivative liability of $175,100. The fair value of $5.12 per share related to the share consideration was determined with reference to the quoted market price of the Company’s stock on the date of issuance. (iv) During the nine months ended October 31, 2014, the Company repaid various convertible promissory notes in the aggregate principal amount of $133,500 through cash payments of $189,640. The repayment of these promissory resulted in net gains on extinguishment of debt of $30,693, being the cash consideration paid upon redemption less the carrying value of the Note and any related embedded conversion features of $64,900, which were being accounted for as derivative financial instruments.

Derivative financial instrument

Derivative financial instruments	9 Months Ended
	Oct. 31, 2015
Derivative financial instruments [Text Block]	11. Derivative financial instruments The following table presents the components of the Company’s derivative financial instruments associated with convertible promissory notes (Notes 10(i)), which have no observable market data and were derived using an option pricing model measured at fair value on a recurring basis, using Level 3 inputs to the fair value hierarchy, at October 31, 2015 and January 31, 2015: October 31, January 31, 2015 2015 Embedded conversion features $ - $ 1,769,100 Warrants - 2,030,850 $ - $ 3,799,950 These derivative financial instruments arose as a result of applying ASC 815 Derivative and Hedging From time to time, the Company has issued notes with embedded conversion features which contain price-protection features that result in these instruments being treated as derivatives. In addition, during the year ended January 31, 2015, the Company issued notes with embedded conversion features and warrants to purchase common stock and the Company did not, at the date of issuance of these instruments, have a sufficient number of authorized and available shares of common stock to settle the outstanding contracts (Note 10(i)). Further, these embedded conversion features and warrants issued during the year ended January 31, 2015 were subject to a registration rights agreement which, pursuant to the terms of this agreement, triggered the requirement to account for these instruments as derivative financial instruments until such time as the shares become eligible for sale without volume limitations or other restrictions. As a result, the Company was required to account for these instruments as derivative financial instruments until such time as the shares were no longer subject to the constraints of the registration rights agreement. During the year ended January 31, 2015, the Company received stockholder approval through written shareholder consent to increase the authorized shares of common stock in the Company from 2,500,000 to 11,250,000, which amount is now sufficient to fully settle all the outstanding contracts. In addition, during the year ended January 31, 2015, the registration statement covering the resale of certain of the warrants covered under the registration rights agreement that were required to be accounted for as derivative liabilities, was filed with and was declared effective by the Securities and Exchange Commission. Additionally, certain registration exemptions were triggered to permit the resale of certain of the shares underlying embedded conversion features. During the nine months ended October 31, 2015, the Company obtained a waiver of the registration rights agreement from certain remaining debenture holders, waiving their rights under the registration rights agreement that were triggering liability accounting. Consequently, these warrants and embedded conversion features were no longer required to be accounted for as liabilities. Pursuant to the guidance of ASC 815, the Company reclassified the fair value of these instruments on the date of the triggering event or modification into equity, with the change in fair value up to the date of modification being recorded on the consolidated statements of operations as other income. As a result of the application of ASC 815, the Company has recorded these derivative financial instruments for the nine months ended October 31, 2015 and 2014 at their fair value as follows: Nine months ended October 31, 2015 2014 Derivative financial instruments, beginning of the period $ 3,799,950 $ 241,618 Fair value of warrants and embedded conversion features at commitment dates - 20,890,900 Fair value mark to market adjustments (708,900 ) 2,773,982 Extinguishment of derivative liability upon extinguishment of host contract - (240,000 ) Reclassification of derivative liability upon change in triggering events (3,091,050 ) (6,139,000 ) Derivative financial instruments, end of the period $ - $ 17,527,500 During the three and nine months ended October 31, 2015, the Company recorded other income (expenses) of $Nil and $708,900, respectively (2014: $Nil and $(12,028,383), respectively) related to the change in fair value of the warrants and embedded conversion features, which is presented in the change in fair value of derivative financial instruments in the accompanying consolidated statements of operations. The embedded conversion features and warrants accounted for as derivative financial instruments have no observable market and the Company estimated their fair values at January 31, 2015 and as at their reclassification dates using the binomial option pricing model based on the following weighted average management assumptions: Reclassification January 31, Date 2015 Risk-free interest rate 0.89% 0.92% Expected life (years) 3.17 3.42 Expected volatility (1) 115.02% 136.25% Stock price $ 4.40 $ 4.80 Dividend yields 0.00% 0.00% (1) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company estimated expected share price volatility based on the historical share price volatility of comparable entities. During the year ended January 31, 2015, the Company repaid certain promissory notes which contained derivative financial instruments and the corresponding derivative financial instrument were extinguished upon extinguishment of the related host contract.

Stockholders Equity

Stockholders Equity	9 Months Ended
	Oct. 31, 2015
Stockholders Equity [Text Block]	12. Stockholders’ Equity Effective August 10, 2015, the Company effected a reverse stock split of the basis of 1:40. As such, the Company’s authorized capital was decreased from 450,000,000 shares of common stock to 11,250,000 shares of common stock and an aggregate of 53,278,818 shares of common stock issued and outstanding were decreased to 1,331,977 shares of common stock. These financial statements give retroactive effect to such reverse split and all share and per share amounts have been adjusted accordingly. Authorized 11,250,000 shares of common stock, par value $0.001. Nine months ended October 31, 2015 i) In connection with a debt settlement agreement, the Company issued 2,500 common shares to a consultant of the Company. The fair value of $4.80 per share was determined with reference to the quoted market price of the Company’s shares on the date these shares were committed to be issued. There was no gain or loss in connection with the debt settlement agreement. ii) On July 3, 2015, the Company issued an aggregate 205,248 shares of common stock at $4 per share, in connection with warrant amendment agreements (the “Warrant Amendments”) for gross proceeds of $821,000. Under the terms of the Warrant Amendments, the holders of such warrants elected to reduce the exercise price of the warrants from $6 to $4, subject to a shortened exercise period and subject to certain resale restrictions on the shares issuable upon exercise of such warrants. Of the total, an aggregate of 140,249 of the shares issued were issued to a director and officer of the Company and a director of the Company for an aggregate exercise price of $560,996. The Company determined that the Warrant Amendments must be accounted for using modification accounting pursuant to the guidance under Accounting Standards Codification 718 (“ASC 718 ”). Under this guidance, a short-term inducement offer shall be accounted for as a modification of the terms of equity based awards, to the extent that the inducement is accepted by the equity holders. Modification accounting requires the incremental fair value of the instrument arising from the modification to be recognized as an expense on the income statement, or a charge directly to equity, depending on the nature of the offer. The Company determined that it was appropriate to record the incremental fair value of the Warrant Amendments as an expense on the income statement and consequently the Company recorded the incremental fair value as a component of general and administrative expenses on the consolidated statement of operations for the three and nine months ended October 31, 2015. The Company determined that the incremental fair value of the instruments arising from the modification was $32,800, based on the difference between the fair value of the warrants immediately prior to the amendment and the fair value of these instruments immediately after the amendment. The fair values were determined using the Black Scholes option pricing model based on the following assumptions: risk free interest rate 1.33%, expected life: 3.94 years, expected volatility: 139.54%, dividend yields: 0.00%. iii) On August 3, 2015, the Company consummated a tender offer to amend and exercise certain warrants to purchase common stock of the Company. Under the terms of the tender offer, the holders of such warrants elected to reduce the exercise price of the warrants from $6 to $4, subject to a shortened exercise period and subject to certain resale restrictions on the shares issuable upon exercise of such warrants. Pursuant to the tender offer, the holders of an aggregate of 380,457 warrants agreed to amend their warrants and tendered and exercised such warrants for gross proceeds to the Company of $1,521,996. In connection with the Tender Offer, the Company incurred issuance costs of $91,422. 2014 Stock Option Plan On June 6, 2014, the Company’s board of directors approved a 2014 Long-Term Incentive Plan (the “2014 Plan”), which provides for the grant of stock options, restricted shares, restricted share units and performance stock and units to directors, officers, employees and consultants of the Company. Stockholder approval of the plan was obtained on August 21, 2014. The maximum number of our common shares reserved for issue under the plan is 2,750,000 shares subject to adjustment in the event of a change of the Company’s capitalization (as described in the 2014 Plan). As a result of the adoption of the 2014 Plan, no further option awards will be granted under any previously existing stock option plan. Stock option awards previously granted under previously existing stock option plans remain outstanding in accordance with their terms. The 2014 Plan is administered by the board of directors, except that it may, in its discretion, delegate such responsibility to a committee of such board. The exercise price will be determined by the board of directors at the time of grant. Stock options may be granted under the 2014 Plan for an exercise period of up to ten years from the date of grant of the option or such lesser periods as may be determined by the board, subject to earlier termination in accordance with the terms of the 2014 Plan. At October 31, 2015, 607,101 options remain available for issuance under the 2014 Plan. Stock Based Compensation A summary of the status of the Company’s outstanding stock options for the periods ended October 31, 2015 and January 31, 2015 is presented below: Weighted Weighted Average Number Average Grant Date of Options Exercise Price Fair Value Outstanding at February 1, 2014 75,125 $ 13.60 Expired (7,125 ) $ 10.00 Granted 1,726,875 $ 5.20 $ 8.40 Outstanding at January 31, 2015 1,794,875 $ 5.48 $ 8.40 Expired (9,375 ) $ 23.33 Forfeited (3,750 ) $ 4.48 Granted 422,399 $ 4.48 $ 4.16 Outstanding at October 31, 2015 2,204,149 $ 5.22 Exercisable at October 31, 2015 1,113,471 $ 5.49 Exercisable at January 31, 2015 346,563 $ 6.80 At October 31, 2015, the following stock options were outstanding, entitling the holder thereof to purchase common shares of the Company as follows: Exercise Expiry Number Number Price Date Vested 375 $ 10.00 December 19, 2015 375 3,750 $ 14.00 January 6, 2016 3,750 3,750 $ 22.00 January 6, 2016 3,750 5,000 $ 30.00 January 6, 2016 5,000 1,375 $ 10.00 April 1, 2016 1,375 15,000 $ 10.00 October 9, 2017 15,000 1,250 $ 10.00 February 1, 2018 1,250 3,750 $ 10.00 May 1, 2018 3,750 2,000 $ 10.00 April 1, 2019 2,000 25,000 $ 10.00 July 30, 2022 25,000 1,699,250 $ 5.12 June 6, 2024 949,750 25,000 $ 6.00 June 10, 2024 15,000 37,500 $ 4.48 February 3, 2025 - 37,500 $ 4.48 February 25, 2025 - 6,250 $ 4.80 July 6, 2025 - 337,399 $ 4.40 August 18, 2025 87,471 2,204,149 1,113,471 The aggregate intrinsic value of stock options outstanding is calculated as the difference between the exercise price of the underlying awards and the fair value of the Company’s common stock. At October 31, 2015, the aggregate intrinsic value of stock options outstanding is $Nil and exercisable is $Nil (January 31, 2015: $Nil and $Nil, respectively). During the three and nine months ended October 31, 2015, the Company recognized a total fair value of $1,613,117 and $4,065,628, respectively (2014: $1,973,875 and $2,094,586, respectively) of stock based compensation expense relating to the issuance of stock options in exchange for services. An amount of approximately $9,232,000 in stock based compensation expense is expected to be recognized over the remaining vesting term of these options to August, 2018. The fair value of each option award was estimated on the date of the grant using the Black-Scholes option pricing model based on the following weighted average assumptions: 2015 2014 Expected term of stock option (years) (1) 6.43 2.14 Expected volatility (2) 124.33% 142.13% Stock price at date of issuance $ 4.71 $ 5.60 Risk-free interest rate 1.81% 0.53% Dividend yields 0.00% 0.00% (1) As the Company has insufficient historical data on which to estimate the expected term of the options, the Company has elected to apply the short-cut method to determine the expected term under the guidance of Staff Accounting Bulletin No. 110 (“SAB 110”). . (2) As the Company has insufficient historical data on which to estimate expected future share price volatility, the Company has estimated expected share price volatility based on the historical share price volatility of comparable entities. Share Purchase Warrants At October 31, 2015, the Company had 1,508,018 share purchase warrants outstanding as follows: Exercise Expiry Number Price Date 6,250 $ 4.00 November 14, 2016 6,250 $ 4.00 November 26, 2016 5,688 $ 4.00 December 24, 2016 12,451 $ 10.00 August 10, 2017 3,750 $ 10.00 August 10, 2018 60,001 $ 6.00 April 4, 2019 555,968 $ 6.00 June 10, 2019 155,052 $ 3.00 June 10, 2019 168,883 $ 6.00 July 8, 2019 29,343 $ 3.00 July 8, 2019 24,625 $ 8.00 October 23, 2019 365,688 $ 4.80 June 15, 2022 36,569 (1) $ 4.80 June 15, 2022 15,000 $ 4.80 July 6, 2022 62,500 $ 5.11 September 1, 2022 1,508,018 (1) These warrants may vest and become exercisable only under certain anti-dilution performance conditions contained in the warrant During the nine months ended October 31, 2015, the Company issued an aggregate of 479,757 warrants exercisable at a weighted average exercise price of $4.84 per share for a period of seven years from the date of issuance, pursuant to negotiated consulting and endorsement agreements. The weighted average grant date fair value of these warrants at issuance was $4.61 for an aggregate grant date fair value of $2,239,000, based on the Black-Scholes option pricing model using the following weighted average assumptions: expected term 7 years, expected volatility 153.15%, expected dividend yield 0.00%, risk free interest rate 2.12% . Stock based compensation is being recorded in the financial statements over the vesting term of three years from the date of grant. The Company recognized stock based compensation expense of $165,849 and $325,648 during the three and nine months ended October 31, 2015, respectively (2014: $Nil and $Nil, respectively) in connection with warrants granted. Certain of the warrants granted during the nine months ended October 31, 2015 become exercisable only under certain anti-dilution performance conditions contained in the warrant agreement. The fair value of these warrants at issuance was calculated to be $168,530 based on the Black-Scholes option pricing model using the following assumptions: expected term 7 years, expected volatility 153.00%, expected dividend yield 0.00%, risk free interest rate 2.11% . No stock-based compensation has been recorded in the financial statements as none of the performance conditions have yet been met. A summary of the Company’s share purchase warrants outstanding is presented below: Number of Weighted Average Warrants Exercise Price Outstanding at February 1, 2014 94,262 $ 16.00 Cancelled (15,000 ) $ 20.00 Issued 1,579,581 $ 5.60 Expired (30,262 ) $ 25.60 Outstanding at January 31, 2015 1,628,581 $ 5.74 Issued 479,757 $ 4.84 Exercised (585,709 ) $ 4.00 Expired (14,611 ) $ 9.82 Outstanding at October 31, 2015 1,508,018 $ 5.10

Customer Concentrations

Customer Concentrations	9 Months Ended
	Oct. 31, 2015
Customer Concentrations [Text Block]	13. Customer Concentrations The Company has concentrations in the volumes of business transacted with particular customers. The loss of these customers could have a material adverse effect on the Company’s business. For the three and nine months ended October 31, 2015, the Company had concentrations of sales with a customer equal to 40% and 43%, respectively of the Company’s net sales (2014: 29% and 34%, respectively). As at October 31, 2015 the accounts receivable balance for this customer was $80,770 (January 31, 2015: $2,755).

Commitments

Commitments	9 Months Ended
	Oct. 31, 2015
Commitments [Text Block]	14. Commitments In accordance with a negotiated agreement, the Company paid a non-refundable guaranteed advance on royalties of $50,000, and is required to pay royalty fees based on the greater of a pre-determined percentage not to exceed 10% of net wholesale sales, as defined in such agreements, or a minimum annual amount. The $50,000 will be charged to operations during the fourth quarter ended January 31, 2016, beginning on the first day of the period for which royalties accrue under the terms of the related agreement. The Company is committed to minimum royalty payments as follows: Year ending January 31, Amount 2016 $ 200,000 2017 362,500 2018 350,000 2019 350,000 2020 87,500 $ 1,350,000

Basis of Presentation (Tables)

Basis of Presentation (Tables)	9 Months Ended
	Oct. 31, 2015
Schedule of Assumptions used for Fair Value of Convertible Promissory Notes [Table Text Block]	October 31, 2015 January 31 2015 Risk-free interest rate 0.66% 0.61% Expected life (years) 1.59 2.34 Expected volatility (1) 133.05% 147.42% Stock price $ 3.18 $ 4.80 Dividend yields 0.00% 0.00%
Revenue from External Customers by Geographic Areas [Table Text Block]	Three months ended Nine months ended October 31, October 31, 2015 2014 2015 2014 United States $ 267,448 $ 78,840 722,039 $ 270,003 Canada 50,300 66,950 216,118 160,587 $ 317,748 $ 145,790 938,157 $ 430,590
Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]	October 31, 2015 January 31, 2015 Equipment Intangible assets Equipment Intangible assets United States $ 9,793 $ 41,990 $ 12,688 $ 14,211 Canada 6,636 29,945 8,453 29,945 $ 16,429 $ 71,935 $ 21,141 $ 44,156
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three months ended October 31, Nine months ended October 31, 2015 2014 2015 2014 Numerator Net income (loss) $ (3,533,421 ) 7,227,623 $ (8,483,089 ) $ (23,039,610 ) Less: Adjustment to income - (10,103,774 ) - - $ (3,533,421 ) $ (2,876,151 ) $ (8,483,089 ) $ (23,039,610 ) Denominator Weighted average common shares outstanding 1,695,437 910,089 1,302,714 888,265 Effect of dilutive securities Warrants - 1,494,900 - - Convertible debt - 2,496,611 - - Diluted weighted average common shares outstanding 1,695,437 4,901,600 1,302,714 888,265 Basic net income (loss) per share $ (2.08 ) $ 7.94 $ (6.51 ) $ (25.94 ) Diluted net income (loss) per share $ (2.08 ) $ (0.59 ) $ (6.51 ) $ (25.94 ) Anti-dilutive securities not included in diluted loss per share relating to: Warrants and options outstanding 3,712,167 1,951,874 3,712,167 3,446,774 Convertible debt 2,372,150 - 2,372,150 2,496,611 6,084,317 1,951,874 6,084,317 5,943,385

Inventory (Tables)

Inventory (Tables)	9 Months Ended
	Oct. 31, 2015
Schedule of Inventory, Current [Table Text Block]	October 31, January 31, 2015 2015 Finished goods $ 1,423,185 $ 362,226 Raw materials 9,202 - 1,432,387 362,226 Less: allowance for obsolete inventory (91,000 ) (179,000 ) Total inventory $ 1,341,387 $ 183,226

Equipment (Tables)

Equipment (Tables)	9 Months Ended
	Oct. 31, 2015
Schedule of Property, Plant and Equipment [Table Text Block]	October 31, January 31, 2015 2015 Furniture & equipment $ 10,250 $ 11,630 Computer equipment 25,400 20,963 35,650 32,593 Less: Accumulated depreciation (19,221 ) (11,452 ) $ 16,429 $ 21,141

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Oct. 31, 2015
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	October 31, January 31, Useful life 2015 2015 (Years) Trade Names/Trademarks $ 71,935 $ 39,781 Indefinite Website 49,512 49,512 2 121,447 89,293 Less: accumulated amortization (49,512 ) (45,137 ) $ 71,935 $ 44,156

Convertible Promissory Notes 25

Convertible Promissory Notes Payable (Tables)	9 Months Ended
	Oct. 31, 2015
Schedule of Convertible Promissory Notes Payable [Table Text Block]	October 31, 2015 January 31, 2015 Senior Secured Convertible Debentures, bearing interest at 6% per annum, collateralized by a priority general security agreement over all of the present and future assets of the company ranked pari passu to First and Second Kalamalka Amendment Agreement, due June 10, 2017 (i). $ 6,936,450 $ 7,169,832 First and Second Kalamalka Amendment Agreement, bearing interest at 6% per annum, collateralized by a priority general security agreement over all of the present and future assets of the company ranked pari passu to Senior Secured Convertible Debentures due June 10, 2017 (ii) 600,000 600,000 Less: debt discounts (6,885,087 ) (7,163,982 ) $ 651,363 $ 605,850
At Issuance [Member]
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	June 10, 2014 July 8, 2014 Risk-free interest rate 1.71% 1.70% Expected life (years) 5.00 5.00 Expected volatility (1) 147.39% 147.39% Stock price at issuance $ 6.00 $ 6.50 Dividend yields 0.00% 0.00%
Agents Warrants and Lender Warrants [Member]
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	Risk-free interest rate 0.66% Expected life (years) 2.50 Expected volatility (1) 141.72% Stock price $ 9.20 Dividend yields 0.00%
New Warrants [Member]
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	Risk-free interest rate 1.71% Expected life (years) 5.00 Expected volatility (1) 149.76% Stock price at date of issuance $ 9.20 Dividend yields 0.00%
Exchanged Warrants [Member]
Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants [Table Text Block]	Existing Exchanged Warrants Warrants Risk-free interest rate 0.96% 1.71% Expected life (years) 3.52 5.00 Expected volatility (1) 146.70% 149.76% Stock price at date of issuance $ 9.20 $ 9.20 Dividend yields 0.00% 0.00%

Derivative financial instrume26

Derivative financial instruments (Tables)	9 Months Ended
	Oct. 31, 2015
Schedule of Derivative Instruments [Table Text Block]	October 31, January 31, 2015 2015 Embedded conversion features $ - $ 1,769,100 Warrants - 2,030,850 $ - $ 3,799,950
Schedule of Derivative Liabilities at Fair Value [Table Text Block]	Nine months ended October 31, 2015 2014 Derivative financial instruments, beginning of the period $ 3,799,950 $ 241,618 Fair value of warrants and embedded conversion features at commitment dates - 20,890,900 Fair value mark to market adjustments (708,900 ) 2,773,982 Extinguishment of derivative liability upon extinguishment of host contract - (240,000 ) Reclassification of derivative liability upon change in triggering events (3,091,050 ) (6,139,000 ) Derivative financial instruments, end of the period $ - $ 17,527,500
Schedule of Assumptions used for Fair Value of Derivative Liabilities [Table Text Block]	Reclassification January 31, Date 2015 Risk-free interest rate 0.89% 0.92% Expected life (years) 3.17 3.42 Expected volatility (1) 115.02% 136.25% Stock price $ 4.40 $ 4.80 Dividend yields 0.00% 0.00%

Stockholders Equity (Tables)

Stockholders Equity (Tables)	9 Months Ended
	Oct. 31, 2015
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Weighted Weighted Average Number Average Grant Date of Options Exercise Price Fair Value Outstanding at February 1, 2014 75,125 $ 13.60 Expired (7,125 ) $ 10.00 Granted 1,726,875 $ 5.20 $ 8.40 Outstanding at January 31, 2015 1,794,875 $ 5.48 $ 8.40 Expired (9,375 ) $ 23.33 Forfeited (3,750 ) $ 4.48 Granted 422,399 $ 4.48 $ 4.16 Outstanding at October 31, 2015 2,204,149 $ 5.22 Exercisable at October 31, 2015 1,113,471 $ 5.49 Exercisable at January 31, 2015 346,563 $ 6.80
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]	Exercise Expiry Number Number Price Date Vested 375 $ 10.00 December 19, 2015 375 3,750 $ 14.00 January 6, 2016 3,750 3,750 $ 22.00 January 6, 2016 3,750 5,000 $ 30.00 January 6, 2016 5,000 1,375 $ 10.00 April 1, 2016 1,375 15,000 $ 10.00 October 9, 2017 15,000 1,250 $ 10.00 February 1, 2018 1,250 3,750 $ 10.00 May 1, 2018 3,750 2,000 $ 10.00 April 1, 2019 2,000 25,000 $ 10.00 July 30, 2022 25,000 1,699,250 $ 5.12 June 6, 2024 949,750 25,000 $ 6.00 June 10, 2024 15,000 37,500 $ 4.48 February 3, 2025 - 37,500 $ 4.48 February 25, 2025 - 6,250 $ 4.80 July 6, 2025 - 337,399 $ 4.40 August 18, 2025 87,471 2,204,149 1,113,471
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	2015 2014 Expected term of stock option (years) (1) 6.43 2.14 Expected volatility (2) 124.33% 142.13% Stock price at date of issuance $ 4.71 $ 5.60 Risk-free interest rate 1.81% 0.53% Dividend yields 0.00% 0.00%
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Exercise Expiry Number Price Date 6,250 $ 4.00 November 14, 2016 6,250 $ 4.00 November 26, 2016 5,688 $ 4.00 December 24, 2016 12,451 $ 10.00 August 10, 2017 3,750 $ 10.00 August 10, 2018 60,001 $ 6.00 April 4, 2019 555,968 $ 6.00 June 10, 2019 155,052 $ 3.00 June 10, 2019 168,883 $ 6.00 July 8, 2019 29,343 $ 3.00 July 8, 2019 24,625 $ 8.00 October 23, 2019 365,688 $ 4.80 June 15, 2022 36,569 (1) $ 4.80 June 15, 2022 15,000 $ 4.80 July 6, 2022 62,500 $ 5.11 September 1, 2022 1,508,018
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]	Number of Weighted Average Warrants Exercise Price Outstanding at February 1, 2014 94,262 $ 16.00 Cancelled (15,000 ) $ 20.00 Issued 1,579,581 $ 5.60 Expired (30,262 ) $ 25.60 Outstanding at January 31, 2015 1,628,581 $ 5.74 Issued 479,757 $ 4.84 Exercised (585,709 ) $ 4.00 Expired (14,611 ) $ 9.82 Outstanding at October 31, 2015 1,508,018 $ 5.10

Commitments (Tables)

Commitments (Tables)	9 Months Ended
	Oct. 31, 2015
Schedule of Minimum Royalty Payments [Table Text Block]	Year ending January 31, Amount 2016 $ 200,000 2017 362,500 2018 350,000 2019 350,000 2020 87,500 $ 1,350,000

Nature of Business (Narrative)

Nature of Business (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015shares
Nature Of Business 1	450,000,000
Nature Of Business 2	11,250,000
Nature Of Business 3	53,278,818
Nature Of Business 4	1,331,977

Basis of Presentation (Narrativ

Basis of Presentation (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Basis Of Presentation 1	$ 14,110,100
Basis Of Presentation 2	$ 15,476,300
Basis Of Presentation 3	18.00%

Inventory (Narrative) (Details)

Inventory (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Inventory 1	$ 91,000
Inventory 2	$ 179,000

Equipment (Narrative) (Details)

Equipment (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Equipment 1	$ 2,943
Equipment 2	9,151
Equipment 3	2,155
Equipment 4	$ 4,179

Intangible Assets (Narrative) (

Intangible Assets (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Intangible Assets 1	$ 0
Intangible Assets 2	4,375
Intangible Assets 3	3,874
Intangible Assets 4	$ 15,002

Related Party Transactions an34

Related Party Transactions and Balances (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)$ / shares$ / yrshares
Related Party Transactions And Balances 1	$ 24,186
Related Party Transactions And Balances 2	17,060
Related Party Transactions And Balances 3	953,779
Related Party Transactions And Balances 4	978,779
Related Party Transactions And Balances 5	22,420
Related Party Transactions And Balances 6	8,247
Related Party Transactions And Balances 7	7,063
Related Party Transactions And Balances 8	791
Related Party Transactions And Balances 9	1,612,952
Related Party Transactions And Balances 10	4,017,737
Related Party Transactions And Balances 11	1,872,467
Related Party Transactions And Balances 12	1,975,515
Related Party Transactions And Balances 13	71,646
Related Party Transactions And Balances 14	230,728
Related Party Transactions And Balances 15	43,500
Related Party Transactions And Balances 16	$ 89,000
Related Party Transactions And Balances 17 | shares	1,875
Related Party Transactions And Balances 18 | shares	7,500
Related Party Transactions And Balances 19	$ 0
Related Party Transactions And Balances 20	43,500
Related Party Transactions And Balances 21	$ 157,300
Related Party Transactions And Balances 22 | $ / yr	400,000
Related Party Transactions And Balances 23 | shares	1,428,750
Related Party Transactions And Balances 24	20.00%
Related Party Transactions And Balances 25 | $ / shares	$ 5.12
Related Party Transactions And Balances 26 | shares	2,500
Related Party Transactions And Balances 27 | $ / shares	$ 4.80
Related Party Transactions And Balances 28	$ 203,702
Related Party Transactions And Balances 29	170,369
Related Party Transactions And Balances 30	$ 166,665
Related Party Transactions And Balances 31	3.00%
Related Party Transactions And Balances 32 | $ / yr	200,000
Related Party Transactions And Balances 33 | shares	70,000
Related Party Transactions And Balances 34 | $ / shares	$ 5.12
Related Party Transactions And Balances 35 | $ / yr	175,000
Related Party Transactions And Balances 36 | shares	92,500
Related Party Transactions And Balances 37 | $ / shares	$ 5.12

Factoring Line of Credit (Narra

Factoring Line of Credit (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Factoring Line Of Credit 1	$ 750,000
Factoring Line Of Credit 2	80.00%
Factoring Line Of Credit 3	60.00%
Factoring Line Of Credit 4	100.00%
Factoring Line Of Credit 5	0.90%
Factoring Line Of Credit 6	$ 14,147
Factoring Line Of Credit 7	24,500
Factoring Line Of Credit 8	0
Factoring Line Of Credit 9	$ 0
Factoring Line Of Credit 10	5.50%
Factoring Line Of Credit 11	2.00%
Factoring Line Of Credit 12	3.25%
Factoring Line Of Credit 13	5.50%
Factoring Line Of Credit 14	1.00%
Factoring Line Of Credit 15	$ 580,407
Factoring Line Of Credit 16	$ 0

Promissory Notes Payable (Narra

Promissory Notes Payable (Narrative) (Details) - 9 months ended Oct. 31, 2015	USD ($)$ / sharesshares	CADshares
Promissory Notes Payable 1 | CAD		CAD 28,750
Promissory Notes Payable 2	$ 24,467
Promissory Notes Payable 3 | CAD		CAD 25,000
Promissory Notes Payable 4	15.00%	15.00%
Promissory Notes Payable 5	$ 3,670
Promissory Notes Payable 6 | CAD		CAD 3,750
Promissory Notes Payable 7	3,450
Promissory Notes Payable 8 | CAD		3,750
Promissory Notes Payable 9	$ 3,450
Promissory Notes Payable 10 | CAD		CAD 3,750
Promissory Notes Payable 11	6.00%	6.00%
Promissory Notes Payable 12	$ 1,083,797
Promissory Notes Payable 13	878,704
Promissory Notes Payable 14	76,388
Promissory Notes Payable 15	128,705
Promissory Notes Payable 16	$ 1,083,797
Promissory Notes Payable 17	6.00%	6.00%
Promissory Notes Payable 18	$ 10,362
Promissory Notes Payable 19	90.00%	90.00%
Promissory Notes Payable 20	$ 121,573
Promissory Notes Payable 21	89,849
Promissory Notes Payable 22	0
Promissory Notes Payable 23	0
Promissory Notes Payable 24	0
Promissory Notes Payable 25	10,372
Promissory Notes Payable 26	0
Promissory Notes Payable 27	0
Promissory Notes Payable 28	0
Promissory Notes Payable 29	89,849
Promissory Notes Payable 30	75,000
Promissory Notes Payable 31	$ 75,000
Promissory Notes Payable 32	10.00%	10.00%
Promissory Notes Payable 33 | shares	19,922	19,922
Promissory Notes Payable 34	$ 4,685
Promissory Notes Payable 35	$ 119,528
Promissory Notes Payable 36 | $ / shares	$ 10
Promissory Notes Payable 37 | CAD		CAD 61,295
Promissory Notes Payable 38	$ 48,464
Promissory Notes Payable 39 | CAD		CAD 53,300
Promissory Notes Payable 40	15.00%	15.00%
Promissory Notes Payable 41	$ 7,270
Promissory Notes Payable 42 | CAD		CAD 7,995
Promissory Notes Payable 43	309,062
Promissory Notes Payable 44	250,000
Promissory Notes Payable 45	$ 37,500
Promissory Notes Payable 46	15.00%	15.00%
Promissory Notes Payable 47	$ 21,562
Promissory Notes Payable 48	41,667
Promissory Notes Payable 49	$ 63,229

Convertible Promissory Notes 37

Convertible Promissory Notes Payable (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)d$ / sharesshares
Convertible Promissory Notes Payable 1	$ 7,309,832
Convertible Promissory Notes Payable 2 | shares	292
Convertible Promissory Notes Payable 3	$ 25,000
Convertible Promissory Notes Payable 4	6.00%
Convertible Promissory Notes Payable 5	$ 25,000
Convertible Promissory Notes Payable 6	4,167
Convertible Promissory Notes Payable 7 | $ / shares	$ 6
Convertible Promissory Notes Payable 8	$ 7,309,832
Convertible Promissory Notes Payable 9	$ 6,094,100
Convertible Promissory Notes Payable 10	6.00%
Convertible Promissory Notes Payable 11	$ 1,094,159
Convertible Promissory Notes Payable 12	$ 1,215,732
Convertible Promissory Notes Payable 13	90.00%
Convertible Promissory Notes Payable 14	6.00%
Convertible Promissory Notes Payable 15	$ 5,537,577
Convertible Promissory Notes Payable 16 | shares	55,377
Convertible Promissory Notes Payable 17	$ 166,127
Convertible Promissory Notes Payable 18	3
Convertible Promissory Notes Payable 19	$ 280,231
Convertible Promissory Notes Payable 20 | $ / shares	$ 3
Convertible Promissory Notes Payable 21	1,218,308
Convertible Promissory Notes Payable 22 | shares	1,218,308
Convertible Promissory Notes Payable 23 | $ / shares	$ 6
Convertible Promissory Notes Payable 24 | $ / shares	$ 16
Convertible Promissory Notes Payable 25	20
Convertible Promissory Notes Payable 26 | d	30
Convertible Promissory Notes Payable 27 | shares	2,500,000
Convertible Promissory Notes Payable 28	$ 19,338,215
Convertible Promissory Notes Payable 29	7,309,832
Convertible Promissory Notes Payable 30	12,028,383
Convertible Promissory Notes Payable 31	26,927
Convertible Promissory Notes Payable 32	45,867
Convertible Promissory Notes Payable 33	1,684
Convertible Promissory Notes Payable 34	2,205
Convertible Promissory Notes Payable 35	2,021,213
Convertible Promissory Notes Payable 36	$ 468,513
Convertible Promissory Notes Payable 37	8.00%
Convertible Promissory Notes Payable 38 | shares	276,592
Convertible Promissory Notes Payable 39	8.00%
Convertible Promissory Notes Payable 40	100.00%
Convertible Promissory Notes Payable 41	$ 1,552,700
Convertible Promissory Notes Payable 42	100.00%
Convertible Promissory Notes Payable 43 | shares	1,039,227
Convertible Promissory Notes Payable 44 | shares	60,000
Convertible Promissory Notes Payable 45	979,227
Convertible Promissory Notes Payable 46 | shares	79,025
Convertible Promissory Notes Payable 47 | shares	77,789
Convertible Promissory Notes Payable 48	$ 233,382
Convertible Promissory Notes Payable 49 | shares	1,236
Convertible Promissory Notes Payable 50	$ 3,682
Convertible Promissory Notes Payable 51	232,977
Convertible Promissory Notes Payable 52	0
Convertible Promissory Notes Payable 53	$ 800,000
Convertible Promissory Notes Payable 54	12.00%
Convertible Promissory Notes Payable 55 | $ / shares	$ 30
Convertible Promissory Notes Payable 56	$ 300,000
Convertible Promissory Notes Payable 57	$ 600,000
Convertible Promissory Notes Payable 58	6.00%
Convertible Promissory Notes Payable 59	$ 400,000
Convertible Promissory Notes Payable 60 | $ / shares	$ 20
Convertible Promissory Notes Payable 61 | $ / shares	$ 10
Convertible Promissory Notes Payable 62	12,500
Convertible Promissory Notes Payable 63	$ 20
Convertible Promissory Notes Payable 64	2,500
Convertible Promissory Notes Payable 65	$ 20
Convertible Promissory Notes Payable 66	15,000
Convertible Promissory Notes Payable 67	45,000
Convertible Promissory Notes Payable 68 | $ / shares	$ 6
Convertible Promissory Notes Payable 69 | $ / shares	$ 16
Convertible Promissory Notes Payable 70	20
Convertible Promissory Notes Payable 71 | d	30
Convertible Promissory Notes Payable 72	$ 694,100
Convertible Promissory Notes Payable 73	384,100
Convertible Promissory Notes Payable 74	23,300
Convertible Promissory Notes Payable 75	36,993
Convertible Promissory Notes Payable 76	7,102
Convertible Promissory Notes Payable 77	21,356
Convertible Promissory Notes Payable 78	7,006
Convertible Promissory Notes Payable 79	16,130
Convertible Promissory Notes Payable 80	100,000
Convertible Promissory Notes Payable 81	$ 1,868
Convertible Promissory Notes Payable 82 | shares	25,467
Convertible Promissory Notes Payable 83 | $ / shares	$ 4
Convertible Promissory Notes Payable 84	$ 187,438
Convertible Promissory Notes Payable 85	124,444
Convertible Promissory Notes Payable 86	$ 175,000
Convertible Promissory Notes Payable 87 | shares	8,250
Convertible Promissory Notes Payable 88	$ 0.265
Convertible Promissory Notes Payable 89	60.00%
Convertible Promissory Notes Payable 90 | d	25
Convertible Promissory Notes Payable 91	$ 38,405
Convertible Promissory Notes Payable 92	217,240
Convertible Promissory Notes Payable 93	3,735
Convertible Promissory Notes Payable 94	120,709
Convertible Promissory Notes Payable 95	$ 175,100
Convertible Promissory Notes Payable 96 | $ / shares	$ 5.12
Convertible Promissory Notes Payable 97	$ 133,500
Convertible Promissory Notes Payable 98	189,640
Convertible Promissory Notes Payable 99	30,693
Convertible Promissory Notes Payable 100	$ 64,900

Derivative financial instrume38

Derivative financial instruments (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Derivative Financial Instruments 1	2,500,000
Derivative Financial Instruments 2	11,250,000
Derivative Financial Instruments 3	$ 0
Derivative Financial Instruments 4	708,900
Derivative Financial Instruments 5	0
Derivative Financial Instruments 6	$ (12,028,383)

Stockholders Equity (Narrative)

Stockholders Equity (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)yr$ / sharesshares
Stockholders Equity 1 | shares	450,000,000
Stockholders Equity 2 | shares	11,250,000
Stockholders Equity 3 | shares	53,278,818
Stockholders Equity 4 | shares	1,331,977
Stockholders Equity 5 | shares	11,250,000
Stockholders Equity 6	$ 0.001
Stockholders Equity 7 | shares	2,500
Stockholders Equity 8 | $ / shares	$ 4.80
Stockholders Equity 9 | shares	205,248
Stockholders Equity 10 | $ / shares	$ 4
Stockholders Equity 11	$ 821,000
Stockholders Equity 12	6
Stockholders Equity 13	$ 4
Stockholders Equity 14	140,249
Stockholders Equity 15	$ 560,996
Stockholders Equity 16	718
Stockholders Equity 17	718
Stockholders Equity 18	$ 32,800
Stockholders Equity 19	1.33%
Stockholders Equity 20 | yr	3.94
Stockholders Equity 21	139.54%
Stockholders Equity 22	0.00%
Stockholders Equity 23	$ 6
Stockholders Equity 24	$ 4
Stockholders Equity 25 | shares	380,457
Stockholders Equity 26	$ 1,521,996
Stockholders Equity 27	$ 91,422
Stockholders Equity 28 | shares	2,750,000
Stockholders Equity 29 | shares	607,101
Stockholders Equity 103	$ 0
Stockholders Equity 104	0
Stockholders Equity 105	0
Stockholders Equity 106	0
Stockholders Equity 107	1,613,117
Stockholders Equity 108	4,065,628
Stockholders Equity 109	1,973,875
Stockholders Equity 110	2,094,586
Stockholders Equity 111	$ 9,232,000
Stockholders Equity 123	1,508,018
Stockholders Equity 155 | shares	479,757
Stockholders Equity 156 | $ / shares	$ 4.84
Stockholders Equity 157	$ 4.61
Stockholders Equity 158	$ 2,239,000
Stockholders Equity 159 | yr	7
Stockholders Equity 160	153.15%
Stockholders Equity 161	0.00%
Stockholders Equity 162	2.12%
Stockholders Equity 163	$ 165,849
Stockholders Equity 164	325,648
Stockholders Equity 165	0
Stockholders Equity 166	0
Stockholders Equity 167	$ 168,530
Stockholders Equity 168 | yr	7
Stockholders Equity 169	153.00%
Stockholders Equity 170	0.00%
Stockholders Equity 171	2.11%

Customer Concentrations (Narrat

Customer Concentrations (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Customer Concentrations 1	40.00%
Customer Concentrations 2	43.00%
Customer Concentrations 3	29.00%
Customer Concentrations 4	34.00%
Customer Concentrations 5	$ 80,770
Customer Concentrations 6	$ 2,755

Commitments (Narrative) (Detail

Commitments (Narrative) (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Commitments 1	$ 50,000
Commitments 2	10.00%
Commitments 3	$ 50,000

Schedule of Assumptions used fo

Schedule of Assumptions used for Fair Value of Convertible Promissory Notes (Details)	9 Months Ended
	Oct. 31, 2015
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 1	0.66%
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 2	0.61%
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 3	1.59
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 4	2.34
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 5	133.05%
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 6	147.42%
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 7	3.18
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 8	4.80
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 9	0.00%
Basis Of Presentation Schedule Of Assumptions Used For Fair Value Of Convertible Promissory Notes 10	0.00%

Revenue from External Customers

Revenue from External Customers by Geographic Areas (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Basis Of Presentation Revenue From External Customers By Geographic Areas 1	$ 267,448
Basis Of Presentation Revenue From External Customers By Geographic Areas 2	78,840
Basis Of Presentation Revenue From External Customers By Geographic Areas 3	722,039
Basis Of Presentation Revenue From External Customers By Geographic Areas 4	270,003
Basis Of Presentation Revenue From External Customers By Geographic Areas 5	50,300
Basis Of Presentation Revenue From External Customers By Geographic Areas 6	66,950
Basis Of Presentation Revenue From External Customers By Geographic Areas 7	216,118
Basis Of Presentation Revenue From External Customers By Geographic Areas 8	160,587
Basis Of Presentation Revenue From External Customers By Geographic Areas 9	317,748
Basis Of Presentation Revenue From External Customers By Geographic Areas 10	145,790
Basis Of Presentation Revenue From External Customers By Geographic Areas 11	938,157
Basis Of Presentation Revenue From External Customers By Geographic Areas 12	$ 430,590

Schedule of Disclosure on Geogr

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 1	$ 9,793
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 2	41,990
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 3	12,688
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 4	14,211
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 5	6,636
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 6	29,945
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 7	8,453
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 8	29,945
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 9	16,429
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 10	71,935
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 11	21,141
Basis Of Presentation Schedule Of Disclosure On Geographic Areas, Long-lived Assets In Individual Foreign Countries By Country 12	$ 44,156

Schedule of Earnings Per Share,

Schedule of Earnings Per Share, Basic and Diluted (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 1	$ (3,533,421)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 2	7,227,623
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 3	(8,483,089)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 4	(23,039,610)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 5	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 6	(10,103,774)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 7	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 8	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 9	(3,533,421)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 10	(2,876,151)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 11	(8,483,089)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 12	(23,039,610)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 13	1,695,437
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 14	910,089
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 15	1,302,714
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 16	888,265
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 17	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 18	1,494,900
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 19	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 20	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 21	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 22	2,496,611
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 23	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 24	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 25	1,695,437
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 26	4,901,600
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 27	1,302,714
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 28	$ 888,265
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 29	(2.08)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 30	7.94
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 31	(6.51)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 32	(25.94)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 33	(2.08)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 34	(0.59)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 35	(6.51)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 36	(25.94)
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 37	$ 3,712,167
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 38	1,951,874
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 39	3,712,167
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 40	3,446,774
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 41	2,372,150
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 42	0
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 43	2,372,150
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 44	2,496,611
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 45	6,084,317
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 46	1,951,874
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 47	6,084,317
Basis Of Presentation Schedule Of Earnings Per Share, Basic And Diluted 48	$ 5,943,385

Schedule of Inventory, Current

Schedule of Inventory, Current (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Inventory Schedule Of Inventory, Current 1	$ 1,423,185
Inventory Schedule Of Inventory, Current 2	362,226
Inventory Schedule Of Inventory, Current 3	9,202
Inventory Schedule Of Inventory, Current 4	0
Inventory Schedule Of Inventory, Current 5	1,432,387
Inventory Schedule Of Inventory, Current 6	362,226
Inventory Schedule Of Inventory, Current 7	(91,000)
Inventory Schedule Of Inventory, Current 8	(179,000)
Inventory Schedule Of Inventory, Current 9	1,341,387
Inventory Schedule Of Inventory, Current 10	$ 183,226

Schedule of Property, Plant and

Schedule of Property, Plant and Equipment (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Equipment Schedule Of Property, Plant And Equipment 1	$ 10,250
Equipment Schedule Of Property, Plant And Equipment 2	11,630
Equipment Schedule Of Property, Plant And Equipment 3	25,400
Equipment Schedule Of Property, Plant And Equipment 4	20,963
Equipment Schedule Of Property, Plant And Equipment 5	35,650
Equipment Schedule Of Property, Plant And Equipment 6	32,593
Equipment Schedule Of Property, Plant And Equipment 7	(19,221)
Equipment Schedule Of Property, Plant And Equipment 8	(11,452)
Equipment Schedule Of Property, Plant And Equipment 9	16,429
Equipment Schedule Of Property, Plant And Equipment 10	$ 21,141

Schedule of Acquired Finite-Liv

Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 1	$ 71,935
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 2	39,781
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 3	49,512
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 4	49,512
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 5	2
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 6	121,447
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 7	89,293
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 8	(49,512)
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 9	(45,137)
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 10	71,935
Intangible Assets Schedule Of Acquired Finite-lived Intangible Assets By Major Class 11	$ 44,156

Schedule of Convertible Promiss

Schedule of Convertible Promissory Notes Payable (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 1	6.00%
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 2	$ 6,936,450
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 3	$ 7,169,832
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 4	6.00%
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 5	$ 600,000
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 6	600,000
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 7	(6,885,087)
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 8	(7,163,982)
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 9	651,363
Convertible Promissory Notes Payable Schedule Of Convertible Promissory Notes Payable 10	$ 605,850

Schedule of Fair Value of the A

Schedule of Fair Value of the Agents Warrants, the Lender Warrants and the Bridge Loan Warrants (Details)	9 Months Ended
	Oct. 31, 2015
At Issuance [Member]
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	1.71%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	1.70%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	5
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	5
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	147.39%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 6	147.39%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 7	6
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 8	6.50
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 9	0.00%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 10	0.00%
Agents Warrants and Lender Warrants [Member]
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	0.66%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	2.50
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	141.72%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	9.20
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	0.00%
New Warrants [Member]
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	1.71%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	5
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	149.76%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	9.20
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	0.00%
Exchanged Warrants [Member]
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 1	0.96%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 2	1.71%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 3	3.52
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 4	5
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 5	146.70%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 6	149.76%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 7	9.20
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 8	9.20
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 9	0.00%
Convertible Promissory Notes Payable Schedule Of Fair Value Of The Agents Warrants, The Lender Warrants And The Bridge Loan Warrants 10	0.00%

Schedule of Derivative Instrume

Schedule of Derivative Instruments (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Derivative Financial Instruments Schedule Of Derivative Instruments 1	$ 0
Derivative Financial Instruments Schedule Of Derivative Instruments 2	1,769,100
Derivative Financial Instruments Schedule Of Derivative Instruments 3	0
Derivative Financial Instruments Schedule Of Derivative Instruments 4	2,030,850
Derivative Financial Instruments Schedule Of Derivative Instruments 5	0
Derivative Financial Instruments Schedule Of Derivative Instruments 6	$ 3,799,950

Schedule of Derivative Liabilit

Schedule of Derivative Liabilities at Fair Value (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 1	$ 3,799,950
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 2	241,618
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 3	0
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 4	20,890,900
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 5	(708,900)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 6	2,773,982
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 7	0
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 8	(240,000)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 9	(3,091,050)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 10	(6,139,000)
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 11	0
Derivative Financial Instruments Schedule Of Derivative Liabilities At Fair Value 12	$ 17,527,500

Schedule of Assumptions used 53

Schedule of Assumptions used for Fair Value of Derivative Liabilities (Details)	9 Months Ended
	Oct. 31, 2015
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 1	0.89%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 2	0.92%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 3	3.17
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 4	3.42
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 5	115.02%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 6	136.25%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 7	4.40
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 8	4.80
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 9	0.00%
Derivative Financial Instruments Schedule Of Assumptions Used For Fair Value Of Derivative Liabilities 10	0.00%

Schedule of Share-based Compens

Schedule of Share-based Compensation, Stock Options, Activity (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 1	$ 75,125
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 2	13.60
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 3	$ (7,125)
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 4	10
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 5	$ 1,726,875
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 6	5.20
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 7	8.40
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 8	$ 1,794,875
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 9	5.48
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 10	8.40
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 11	$ (9,375)
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 12	23.33
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 13	$ (3,750)
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 14	4.48
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 15	$ 422,399
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 16	4.48
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 17	4.16
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 18	$ 2,204,149
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 19	5.22
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 20	$ 1,113,471
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 21	5.49
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 22	$ 346,563
Stockholders Equity Schedule Of Share-based Compensation, Stock Options, Activity 23	6.80

Disclosure of Share-based Compe

Disclosure of Share-based Compensation Arrangements by Share-based Payment Award (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 1	$ 375
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 2	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 3	$ 375
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 4	$ 3,750
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 5	14
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 6	$ 3,750
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 7	$ 3,750
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 8	22
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 9	$ 3,750
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 10	$ 5,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 11	30
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 12	$ 5,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 13	$ 1,375
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 14	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 15	$ 1,375
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 16	$ 15,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 17	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 18	$ 15,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 19	$ 1,250
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 20	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 21	$ 1,250
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 22	$ 3,750
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 23	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 24	$ 3,750
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 25	$ 2,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 26	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 27	$ 2,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 28	$ 25,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 29	10
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 30	$ 25,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 31	$ 1,699,250
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 32	5.12
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 33	$ 949,750
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 34	$ 25,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 35	6
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 36	$ 15,000
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 37	$ 37,500
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 38	4.48
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 39	$ 0
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 40	$ 37,500
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 41	4.48
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 42	$ 0
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 43	$ 6,250
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 44	4.80
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 45	$ 0
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 46	$ 337,399
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 47	4.40
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 48	$ 87,471
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 49	2,204,149
Stockholders Equity Disclosure Of Share-based Compensation Arrangements By Share-based Payment Award 50	$ 1,113,471

Schedule of Share-based Payment

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details)	9 Months Ended
	Oct. 31, 2015
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 1	6.43
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 2	2.14
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 3	124.33%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 4	142.13%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 5	4.71
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 6	5.60
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 7	1.81%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 8	0.53%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 9	0.00%
Stockholders Equity Schedule Of Share-based Payment Award, Stock Options, Valuation Assumptions 10	0.00%

Schedule of Stockholders' Equit

Schedule of Stockholders' Equity Note, Warrants or Rights (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 1	$ 6,250
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 2	4
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 3	$ 6,250
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 4	4
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 5	$ 5,688
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 6	4
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 7	$ 12,451
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 8	10
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 9	$ 3,750
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 10	10
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 11	$ 60,001
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 12	6
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 13	$ 555,968
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 14	6
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 15	$ 155,052
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 16	3
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 17	$ 168,883
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 18	6
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 19	$ 29,343
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 20	3
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 21	$ 24,625
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 22	8
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 23	$ 365,688
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 24	4.80
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 25	$ 36,569
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 26	4.80
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 27	$ 15,000
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 28	4.80
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 29	$ 62,500
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 30	5.11
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights 31	$ 1,508,018

Schedule of Stockholders' Equ58

Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1	$ 94,262
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2	16
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3	$ (15,000)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4	20
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5	$ 1,579,581
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6	5.60
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 7	$ (30,262)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 8	25.60
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 9	$ 1,628,581
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 10	5.74
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 11	$ 479,757
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 12	4.84
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 13	$ (585,709)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 14	4
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 15	$ (14,611)
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 16	9.82
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 17	$ 1,508,018
Stockholders Equity Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 18	5.10

Schedule of Minimum Royalty Pay

Schedule of Minimum Royalty Payments (Details)	9 Months Ended
	Oct. 31, 2015USD ($)
Commitments Schedule Of Minimum Royalty Payments 1	$ 200,000
Commitments Schedule Of Minimum Royalty Payments 2	362,500
Commitments Schedule Of Minimum Royalty Payments 3	350,000
Commitments Schedule Of Minimum Royalty Payments 4	350,000
Commitments Schedule Of Minimum Royalty Payments 5	87,500
Commitments Schedule Of Minimum Royalty Payments 6	$ 1,350,000